Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jan 21;18(6):1325-1331.
doi: 10.7150/ijms.52257. eCollection 2021.

Catheter Ablation Compared with Medical Therapy for Atrial Fibrillation with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Kuo-Li Pan  1   2   3 , Yi-Ling Wu  4 , Meng Lee  2   5 , Bruce Ovbiagele  6   7
Affiliations
Meta-Analysis

Catheter Ablation Compared with Medical Therapy for Atrial Fibrillation with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Kuo-Li Pan et al. Int J Med Sci. .

Abstract

Background: The optimal strategy for patients with coexisting atrial fibrillation (AF) and heart failure (HF) was not settled. Our purpose was to conduct a systematic review and meta-analysis of randomized controlled trials to evaluate the effect of catheter ablation compared with medical therapy for AF on mortality, HF hospitalization, left ventricular (LV) function, and quality of life among patients with HF and AF. Materials and Methods: We searched Pubmed (1966 to September 20, 2019), EMBASE (1966 to September 20, 2019), the Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov for randomized controlled trials with a comparison of catheter ablation for AF with medical therapy among patients with coexisting AF and HF. Risk ratio (RR) or mean difference (MD) with 95% confidence interval (CI) was used as a measure of the effect of catheter ablation versus medical therapy on endpoints. Our final analysis included 6 randomized control trials with 775 patients. Results: Pooled results from the random-effects model showed that compared with medical therapy for AF, catheter ablation was associated with reduced all-cause mortality (RR 0.52, 95%Cl, 0.35 to 0.76) and HF hospitalization (RR 0.56, 95%Cl, 0.44 to 0.71), as well as increased LV ejection fraction (LVEF), distance walked in six minutes, and improvements in quality of life. Conclusions: This updated meta-analysis showed that compared to medical therapy, catheter ablation for AF was associated with significant benefits in several key clinical and biomarker endpoints, including reductions in all-cause mortality and HF hospitalization.

Keywords: atrial fibrillation; catheter ablation; heart failure; medical therapy; mortality..

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Flowchart of study selection
Figure 2
Figure 2
Risk ratio with 95% confidence interval of all-cause mortality (catheter ablation for atrial fibrillation vs medical therapy), by trial and pooled. M-H indicates Mantel-Haenszel methods.
Figure 3
Figure 3
Risk ratio with 95% confidence interval of heart failure hospitalization and remained in atrial fibrillation (catheter ablation for atrial fibrillation vs medical therapy), by trial and pooled. HF: heart failure, AF: atrial fibrillation. M-H indicates Mantel-Haenszel methods.
Figure 4
Figure 4
Mean difference with 95% confidence interval in left ventricular ejection fraction (LVEF), 6-minute walk distance, and Minnesota Living with Heart Failure Questionnaire (MLHFQ), by trial and pooled.
See this image and copyright information in PMC

References

    1. Roy D, Talajic M, Nattel S. et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667–2677. - PubMed
    1. Hindricks G, Potpara T, Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2020;0:1–126.
    1. Anselmino M, Matta M, D'Ascenzo F. et al. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: A systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:1011–1018. - PubMed
    1. January CT, Wann LS, Calkins H. et al. 2019 AHA/ACC/HRS Focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104–132. - PubMed
    1. Marrouche NF, Brachmann J, Andresen D. et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–427. - PubMed

MeSH terms

Substances